Increased Serum Levels of S100A1, ZAG, and Adiponectin in Cachectic Patients with COPD

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2018 Oct 24

PMID 30349224

Citations 7

Authors

Amin Mokari-Yamchi

Akbar Sharifi

Sorayya Kheirouri

Affiliations

Soon will be listed here.

Abstract

Background: COPD is a common irreversible obstructive airway disease. S100A1, ZAG, and adiponectin are important regulators of energy metabolism and body weight. Therefore, the aim of this study was to assess resting metabolic rate (RMR) and its association with serum levels of S100A1, ZAG, and adiponectin in cachectic and noncachectic COPD patients.

Patients And Methods: Ninety men with COPD, aged 40-70 years, were enrolled in the study. Patients were divided into the following two groups based on the unintentional weight loss of .7.5% in previous 6 months: noncachectic (n=45) and cachectic (n=45). The groups were matched based on age and body mass index (BMI). RMR was measured by indirect calorimetry method. Anthropometric indices and body composition were also measured. Serum levels of S100A1, ZAG, and adiponectin were measured by ELISA.

Results: Cachectic patients had significantly higher RMR than controls (<0.001). Serum levels of ZAG, S100A1, and adiponectin were significantly higher in the cachexia group (<0.0001). RMR was not significantly associated with S100A1, ZAG, and adiponectin levels. However, weight loss of patients was significantly associated with serum levels of ZAG and adiponectin (both, β=0.22, =0.03). Strong and positive association were found between the serum levels of S100A1 and ZAG (β=0.88, <0.0001), S100A1 and adiponectin (β=0.86, <0.0001), and also ZAG and adiponectin (β=0.83, <0.0001).

Conclusion: The potential role of these factors in the wasting process is considerable. Also, the association between serum levels of S100A1, ZAG, and adiponectin represents that these three proteins are probably related to specific functions.

Citing Articles

Adiponectin as a predictor of mortality and readmission in patients with community-acquired pneumonia: a prospective cohort study.

Matovu Dungu A, Ryrso C, Hegelund M, Sejdic A, Jensen A, Kristensen P Front Med (Lausanne). 2024; 11:1329417.

PMID: 38633314 PMC: 11022597. DOI: 10.3389/fmed.2024.1329417.

Overexpression of S100A1 in Osteosarcoma Inhibits Tumor Proliferation and Progression.

Xing W, Zhao Y, Lin L, Zhao Z, Yang M, Wang N Iran J Public Health. 2023; 51(12):2773-2782.

PMID: 36742226 PMC: 9874206. DOI: 10.18502/ijph.v51i12.11468.

Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician.

De Brandt J, Beijers R, Chiles J, Maddocks M, McDonald M, Schols A Int J Chron Obstruct Pulmon Dis. 2022; 17:2957-2976.

PMID: 36425061 PMC: 9680681. DOI: 10.2147/COPD.S334228.

Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.

Ting C, Chen B Int J Mol Sci. 2022; 23(7).

PMID: 35409008 PMC: 8998971. DOI: 10.3390/ijms23073649.

Lipopolysaccharides induce a RAGE-mediated sensitization of sensory neurons and fluid hypersecretion in the upper airways.

Nair M, Jagadeeshan S, Katselis G, Luan X, Momeni Z, Henao-Romero N Sci Rep. 2021; 11(1):8336.

PMID: 33863932 PMC: 8052339. DOI: 10.1038/s41598-021-86069-6.

References

Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S . Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8(11):1288-95. DOI: 10.1038/nm788. View

Qi Y, Takahashi N, Hileman S, Patel H, Berg A, Pajvani U . Adiponectin acts in the brain to decrease body weight. Nat Med. 2004; 10(5):524-9. DOI: 10.1038/nm1029. View

Ko F, Cheung N, Rainer T, Lum C, Wong I, Hui D . Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial. Thorax. 2016; 72(2):122-128. DOI: 10.1136/thoraxjnl-2016-208396. View

Russell S, Tisdale M . Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein. Endocrinology. 2010; 151(10):4696-704. DOI: 10.1210/en.2010-0532. View

Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

Sin D, Anthonisen N, Soriano J, Agusti A . Mortality in COPD: Role of comorbidities. Eur Respir J. 2006; 28(6):1245-57. DOI: 10.1183/09031936.00133805. View

Huertas A, Palange P . COPD: a multifactorial systemic disease. Ther Adv Respir Dis. 2011; 5(3):217-24. DOI: 10.1177/1753465811400490. View

Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J . The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf). 2009; 72(3):334-41. DOI: 10.1111/j.1365-2265.2009.03658.x. View

Balaz M, Ukropcova B, Kurdiova T, Gajdosechova L, Vlcek M, Janakova Z . Adipokine zinc-α2-glycoprotein regulated by growth hormone and linked to insulin sensitivity. Obesity (Silver Spring). 2014; 23(2):322-8. DOI: 10.1002/oby.20856. View

10.

Felix K, Fakelman F, Hartmann D, Giese N, Gaida M, Schnolzer M . Identification of serum proteins involved in pancreatic cancer cachexia. Life Sci. 2010; 88(5-6):218-25. DOI: 10.1016/j.lfs.2010.11.011. View

11.

Ohashi K, Yuasa D, Shibata R, Murohara T, Ouchi N . Adiponectin as a Target in Obesity-related Inflammatory State. Endocr Metab Immune Disord Drug Targets. 2015; 15(2):145-50. DOI: 10.2174/1871530315666150316122709. View

12.

Araujo J, Lourenco P, Rocha-Goncalves F, Ferreira A, Bettencourt P . Adiponectin is increased in cardiac cachexia irrespective of body mass index. Eur J Heart Fail. 2009; 11(6):567-72. DOI: 10.1093/eurjhf/hfp046. View

13.

Brusik M, Ukropec J, Joppa P, Ukropcova B, Skyba P, Balaz M . Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease. Physiol Res. 2012; 61(5):469-80. DOI: 10.33549/physiolres.932306. View

14.

Schols A, Soeters P, Mostert R, Saris W, Wouters E . Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991; 143(6):1248-52. DOI: 10.1164/ajrccm/143.6.1248. View

15.

Tran L, Hanavan P, Campbell L, De Filippis E, Lake D, Coletta D . Prolonged Exposure of Primary Human Muscle Cells to Plasma Fatty Acids Associated with Obese Phenotype Induces Persistent Suppression of Muscle Mitochondrial ATP Synthase β Subunit. PLoS One. 2016; 11(8):e0160057. PMC: 4988792. DOI: 10.1371/journal.pone.0160057. View

16.

Xiao X, Li H, Qi X, Wang Y, Xu C, Liu G . Zinc alpha2 glycoprotein alleviates palmitic acid-induced intracellular lipid accumulation in hepatocytes. Mol Cell Endocrinol. 2016; 439:155-164. DOI: 10.1016/j.mce.2016.06.003. View

17.

Marenholz I, Heizmann C, Fritz G . S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004; 322(4):1111-22. DOI: 10.1016/j.bbrc.2004.07.096. View

18.

Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M . Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010; 464(7293):1313-9. DOI: 10.1038/nature08991. View

19.

Flint A, Raben A, Blundell J, Astrup A . Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000; 24(1):38-48. DOI: 10.1038/sj.ijo.0801083. View

20.

Ebrahimi E, Kheirouri S, Alizadeh M . Down-regulation of S100A1 protein in patients with metabolic syndrome and its association with zinc-α2-glycoprotein. Scott Med J. 2017; 62(3):88-95. DOI: 10.1177/0036933017727433. View